Top compounds associated with response to CLDN4


Feature Type Standardized
Nominal ANOVA
mRNA austocystin d CTRPv2 pan-cancer AAC 0.23 1e-07
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 3e-07
mRNA EKB-569 GDSC1000 pan-cancer AAC 0.22 1e-06
mRNA Elesclomol GDSC1000 pan-cancer AAC -0.23 2e-06
mRNA niclosamide CTRPv2 pan-cancer AAC -0.2 2e-06
mRNA WZ4002 CTRPv2 pan-cancer AAC 0.24 3e-06
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 4e-06
mRNA GSK269962A GDSC1000 pan-cancer AAC -0.2 5e-06
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 9e-06
mRNA AZD6244 CTRPv2 pan-cancer AAC 0.19 9e-06
Download CSV